Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma
使用血浆 ctDNA、参考标准和源自正常血浆的合成连续稀释样本对商用下一代测序液体活检平台进行分析性能评估
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-020-07445-5
Suman Verma, Mathew W Moore, Rebecca Ringler, Abhisek Ghosal, Kyle Horvath, Theodore Naef, Sheri Anvari, Philip D Cotter, Shelly Gunn